Truncation mutations and allelic losses in the tumor suppressor gene APC are present in around 80% of sporadic CRC cases, whereas a small proportion carries mutations in AXIN2 or CTNNB1/β-catenin genes. This evidence concerns the gene AXIN2 and colorectal carcinoma.